Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5′-untranslated region

Journal of Neuroendocrinology

Volumn 19, Issue 4, 2007, Pages 309-319

  Rabadan Diehl, C ^a   Martinez A ^b   Volpi, S ^a   Subburaju, S ^a   Aguilera, Greti ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INSTITUTO CAJAL   (Spain)

Author keywords

5 untranslated region; In vitro translation; Minicistron; Translational control; Vasopressin V1b receptor

Indexed keywords

COMPLEMENTARY DNA; GLUCOCORTICOID; INOSITOL PHOSPHATE; MESSENGER RNA; METHIONINE; VASOPRESSIN; VASOPRESSIN V1B RECEPTOR;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL STRAIN MCF 7; CHO CELL; CISTRON; COMPUTER ANALYSIS; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; TRANSLATION INITIATION; TRANSLATION REGULATION; WESTERN BLOTTING;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION; MALE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN;

EID: 33847724421     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01533.x     Document Type: Article

References (33)

1. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15: 321-350.
2. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
3. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button DC, Young WS III, Mezey E, Brownstein MJ. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 1995; 92: 6783-6787.
4. Jard S, Barberis C, Audigier S, Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog Brain Res 1987; 72: 173-187.
5. Aguilera G, Pham Q, Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: Relationship to corticotroph responsiveness. J Neuroendocrinol 1994; 6: 299-304.
6. Aguilera G, Volpi S, Rabadan-Diehl C. Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene. J Mol Endocrinol 2003; 30: 99-108.
7. Rabadan-Diehl C, Makara G, Kiss A, Lolait S, Zelena D, Ochedalski T, Aguilera G. Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. Endocrinology 1997; 138: 5189-5194.
8. Rabadan-Diehl C, Lolait SJ, Aguilera G. Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat. J Neuroendocrinol 1995; 7: 903-910.
9. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; 234: 187-208.
10. Shatkin AJ. Capping of eucaryotic mRNAs. Cell 1976; 9: 645-653.
11. Sachs AB, Sarnow P, Hentze MW. Starting at the beginning, middle, and end: Translation initiation in eukaryotes. Cell 1997; 89: 831-838.
12. Kobilka BK, MacGregor C, Daniel K, Kobilka TS, Caron MG, Lefkowitz RJ. Functional activity and regulation of human beta 2-adrenergic receptors expressed in Xenopus oocytes. J Biol Chem 1987; 262: 15796-15802.
13. Xu G, Rabadan-Diehl C, Nikodemova M, Wynn P, Spiess J, Aguilera G. Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5′ untranslated region. Mol Pharmacol 2001; 59: 485-492.
14. Nomura A, Iwasaki Y, Saito M, Aoki Y, Yamamori E, Ozaki N, Tachikawa K, Mutsuga N, Morishita M, Yoshida M, Asai M, Oiso Y, Saito H. Involvement of upstream open reading frames in regulation of rat V(1b) vasopressin receptor expression. Am J Physiol Endocrinol Metab 2001; 280: E780-E787.
15. Rabadan-Diehl C, Aguilera G. Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. Endocrinology 1998; 139: 3220-3226.
16. Rabadan-Diehl C, Lolait SJ, Aguilera G. Isolation and characterization of the promoter region of the rat vasopressin V1b receptor gene. J Neuroendocrinol 2000; 12: 437-444.
17. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene 2002; 299: 1-34.
18. Geballe AP, Morris DR. Initiation codons within 5′-leaders of mRNAs as regulators of translation. Trends Biochem Sci 1994; 19: 159-164.
19. Hunt T. False starts in translational control of gene expression. Nature 1985; 316: 580-581.
20. Hinnebusch AG. Translational regulation of yeast GCN4. A window on factors that control initiator-trna binding to the ribosome. J Biol Chem 1997; 272: 21661-21664.
21. Ventura MA, Rene P, de Keyzer Y, Bertagna X, Clauser E. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor. J Mol Endocrinol 1999; 22: 251-260.
22. de Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna X, Clauser E. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 1994; 356: 215-220.
23. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-27092.
24. Mori Y, Matsubara H, Murasawa S, Kijima K, Maruyama K, Tsukaguchi H, Okubo N, Hamakubo T, Inagami T, Iwasaka T, Inada M. Translational regulation of angiotensin II type 1A receptor. Role of upstream AUG triplets. Hypertension 1996; 28: 810-817.
25. Parola AL, Kobilka BK. The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 1994; 269: 4497-4505.
26. Hernando F, Schoots O, Lolait SJ, Burbach JP. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: Anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2001; 142: 1659-1668.
27. Subburaju S, Aguilera G. Vasopressin mediates pituitary mitogenesis but not increases in the number of ACTH containing corticotrophs. 6th International Congress of Neuroendocrinology, Pittsburgh, PA. Front Neuroendocrinol 2006; 27: 57.
28. McCarthy JE, Kollmus H. Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem Sci 1995; 20: 191-197.
29. Krishnamurthi K, Verbalis JG, Zheng W, Wu Z, Clerch LB, Sandberg K. Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA. Endocrinology 1999; 140: 5435-5438.
30. Giraud S, Greco A, Brink M, Diaz JJ, Delafontaine P. Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem 2001; 276: 5668-5675.
31. Wu Z, Ji H, Hassan A, Aguilera G, Sandberg K. Regulation of pituitary corticotropin releasing factor type-1 receptor mRNA binding proteins by modulation of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 2004; 16: 214-220.
32. Rabadan-Diehl C, Volpi S, Nikodemova M, Aguilera G. Translational regulation of the vasopressin v1b receptor involves an internal ribosome entry site. J Mol Endocrinol 2003; 17: 1959-1971.
33. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-339.